ClinicalTrials.Veeva

Menu

DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry) (DEB-DRAGON)

M

Medical University of Silesia

Status

Completed

Conditions

In Stent Restenosis

Treatments

Device: percutaneous coronary intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Data regarding the usefulness of percutaneous coronary intervention (PCI) with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR) in every day clinical practice is scarce. We aimed to evaluate comparing the efficacy and safety profile of DEB and thin-DES in DES-ISR.

Enrollment

1,369 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

• All consecutive patients with DES-ISR who were treated with either paclitaxel-DEB or thin-DES.

Exclusion criteria

  • PCI with DES struts thickness >100μm
  • PCI with DEB and thin-DES in the same procedure
  • PCI of other vascular territories during the same procedure
  • PCI in saphenous vain graft or internal mammary artery

Trial design

1,369 participants in 2 patient groups

ISR PCI with thin-DES
Treatment:
Device: percutaneous coronary intervention
ISR PCI with DEB
Treatment:
Device: percutaneous coronary intervention

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems